Antiplatelet therapy in secondary prevention of ischemic stroke
The article is a review of literature on antiplatelet (antiagregant) therapy in the secondary prevention of ischemic stroke (IS). The latest guidelines (2014) from the American Heart Association and stroke experts are discussed. The efficacy of acetylsalicylic acid (ASA), extended-release dipyridamo...
Main Authors: | V. A. Parfyonov, S. V. Verbitskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2015-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/165 |
Similar Items
-
ПРОФИЛАКТИКА ПОВТОРНОГО НЕКАРДИОЭМБОЛИЧЕСКОГО ИШЕМИЧЕСКОГО ИНСУЛЬТА НА ОСНОВЕ АНТИТРОМБОЦИТАРНЫХ СРЕДСТВ
Published: (2016-12-01) -
Ученые оценили риски профилактического приема АСК
by: Editorial Article
Published: (2013-12-01) -
Patient-specific choice of an antiplatelet drug for long-term therapy of coronary heart disease: rationale and implementationL
by: NA Mazur
Published: (2014-12-01) -
Case Series about the Changed Antiplatelet Protocol for Carotid Endarterectomy in a Teaching Hospital: More Patients with Complications?
by: Martijn S. Marsman, et al.
Published: (2018-10-01) -
Antiaggregants in cardiology: choice of best individual treatment
by: A. N. Yakovlev
Published: (2015-12-01)